Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit

NCT04210427 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis Gastrointestinal Disease

Interventions

DRUG: Polyethylene Glycol 3350
DEVICE: SmartPill Motility System & PillCam Patency Capsule

Sponsor

St. Louis University